| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | aspartic-type endopeptidase activity | PGA4 ERVK-7 ERVK-10 PGA5 ERVK-8 ERVK-18 ERVK-19 ERVK-25 PGA3 | 3.55e-12 | 37 | 141 | 9 | GO:0004190 |
| GeneOntologyMolecularFunction | aspartic-type peptidase activity | PGA4 ERVK-7 ERVK-10 PGA5 ERVK-8 ERVK-18 ERVK-19 ERVK-25 PGA3 | 4.62e-12 | 38 | 141 | 9 | GO:0070001 |
| GeneOntologyMolecularFunction | RNA-directed DNA polymerase activity | 3.11e-08 | 14 | 141 | 5 | GO:0003964 | |
| GeneOntologyMolecularFunction | RNA-DNA hybrid ribonuclease activity | 7.57e-07 | 11 | 141 | 4 | GO:0004523 | |
| GeneOntologyMolecularFunction | DNA polymerase activity | 6.80e-06 | 38 | 141 | 5 | GO:0034061 | |
| GeneOntologyMolecularFunction | endopeptidase activity | PGA4 CTSF ERVK-7 ERVK-10 ACE PGA5 TMPRSS3 ERVK-8 ERVK-18 ERVK-19 ERVK-25 PCSK4 PGA3 | 1.16e-05 | 430 | 141 | 13 | GO:0004175 |
| GeneOntologyMolecularFunction | RNA stem-loop binding | 1.30e-05 | 21 | 141 | 4 | GO:0035613 | |
| GeneOntologyMolecularFunction | peptidase activity | PGA4 RELN CTSF ANPEP ERVK-7 ERVK-10 ACE PGA5 TMPRSS3 ERVK-8 ERVK-18 ERVK-19 SCPEP1 ERVK-25 PCSK4 PGA3 | 1.58e-05 | 654 | 141 | 16 | GO:0008233 |
| GeneOntologyMolecularFunction | RNA endonuclease activity, producing 5'-phosphomonoesters | 1.31e-04 | 37 | 141 | 4 | GO:0016891 | |
| GeneOntologyMolecularFunction | chloride ion binding | 1.80e-04 | 16 | 141 | 3 | GO:0031404 | |
| GeneOntologyMolecularFunction | endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters | 3.09e-04 | 46 | 141 | 4 | GO:0016893 | |
| GeneOntologyMolecularFunction | peptide binding | KPNA5 ANPEP HLA-DRB3 HLA-DRB4 HLA-DRB5 GSAP ITGA2 PEX5 KPNA1 | 4.38e-04 | 318 | 141 | 9 | GO:0042277 |
| GeneOntologyMolecularFunction | alpha-amylase activity | 4.88e-04 | 5 | 141 | 2 | GO:0004556 | |
| GeneOntologyMolecularFunction | netrin receptor activity | 7.29e-04 | 6 | 141 | 2 | GO:0005042 | |
| GeneOntologyMolecularFunction | amylase activity | 7.29e-04 | 6 | 141 | 2 | GO:0016160 | |
| GeneOntologyMolecularFunction | ADP-ribose diphosphatase activity | 7.29e-04 | 6 | 141 | 2 | GO:0047631 | |
| GeneOntologyMolecularFunction | MHC class II protein complex binding | 8.90e-04 | 27 | 141 | 3 | GO:0023026 | |
| GeneOntologyMolecularFunction | calcium/calmodulin-dependent protein kinase activity | 8.90e-04 | 27 | 141 | 3 | GO:0004683 | |
| GeneOntologyBiologicalProcess | DNA integration | 1.35e-06 | 13 | 139 | 4 | GO:0015074 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of peptide antigen | 1.25e-05 | 76 | 139 | 6 | GO:0048002 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of exogenous peptide antigen | 1.75e-05 | 48 | 139 | 5 | GO:0002478 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation | 4.42e-05 | 139 | 139 | 7 | GO:0019882 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of exogenous antigen | 4.45e-05 | 58 | 139 | 5 | GO:0019884 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of exogenous peptide antigen via MHC class II | 6.13e-05 | 32 | 139 | 4 | GO:0019886 | |
| GeneOntologyBiologicalProcess | regulation of dendrite morphogenesis | 7.03e-05 | 103 | 139 | 6 | GO:0048814 | |
| GeneOntologyBiologicalProcess | protein localization to membrane | RELN CACNA2D2 CAMK2B CAMK2D CAMK2G EMC9 NFASC NBEA ACTN2 TTC7A NRXN3 PEX5 OLFM2 IKBKB SDCBP | 8.44e-05 | 705 | 139 | 15 | GO:0072657 |
| GeneOntologyBiologicalProcess | positive regulation of dendrite morphogenesis | 8.93e-05 | 67 | 139 | 5 | GO:0050775 | |
| GeneOntologyBiologicalProcess | localization within membrane | RELN CACNA2D2 CAMK2B CAMK2D CAMK2G EMC9 NFASC NBEA ACTN2 TTC7A NRXN3 DEF6 PEX5 OLFM2 IKBKB SDCBP | 9.69e-05 | 798 | 139 | 16 | GO:0051668 |
| GeneOntologyBiologicalProcess | antigen processing and presentation of peptide antigen via MHC class II | 9.84e-05 | 36 | 139 | 4 | GO:0002495 | |
| GeneOntologyBiologicalProcess | positive regulation of cell morphogenesis | 1.03e-04 | 69 | 139 | 5 | GO:0010770 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of peptide or polysaccharide antigen via MHC class II | 1.22e-04 | 38 | 139 | 4 | GO:0002504 | |
| GeneOntologyBiologicalProcess | protein localization to cell periphery | CACNA2D2 CAMK2B CAMK2D CAMK2G NFASC NBEA ACTN2 TTC7A NRXN3 OLFM2 IKBKB | 1.38e-04 | 422 | 139 | 11 | GO:1990778 |
| GeneOntologyBiologicalProcess | MHC class II protein complex assembly | 1.57e-04 | 16 | 139 | 3 | GO:0002399 | |
| GeneOntologyBiologicalProcess | peptide antigen assembly with MHC class II protein complex | 1.57e-04 | 16 | 139 | 3 | GO:0002503 | |
| GeneOntologyBiologicalProcess | RNA-templated DNA biosynthetic process | 2.46e-04 | 83 | 139 | 5 | GO:0006278 | |
| GeneOntologyBiologicalProcess | DNA synthesis involved in DNA repair | 3.05e-04 | 48 | 139 | 4 | GO:0000731 | |
| GeneOntologyBiologicalProcess | NLS-bearing protein import into nucleus | 3.14e-04 | 20 | 139 | 3 | GO:0006607 | |
| GeneOntologyBiologicalProcess | neurotransmitter receptor localization to postsynaptic specialization membrane | 3.31e-04 | 49 | 139 | 4 | GO:0099645 | |
| GeneOntologyBiologicalProcess | protein localization to postsynaptic specialization membrane | 3.31e-04 | 49 | 139 | 4 | GO:0099633 | |
| GeneOntologyBiologicalProcess | MHC protein complex assembly | 3.64e-04 | 21 | 139 | 3 | GO:0002396 | |
| GeneOntologyBiologicalProcess | peptide antigen assembly with MHC protein complex | 3.64e-04 | 21 | 139 | 3 | GO:0002501 | |
| GeneOntologyCellularComponent | calcium- and calmodulin-dependent protein kinase complex | 2.85e-06 | 5 | 139 | 3 | GO:0005954 | |
| GeneOntologyCellularComponent | multivesicular body lumen | 9.88e-06 | 7 | 139 | 3 | GO:0097486 | |
| GeneOntologyCellularComponent | late endosome lumen | 4.57e-05 | 11 | 139 | 3 | GO:0031906 | |
| GeneOntologyCellularComponent | MHC class II protein complex | 1.83e-04 | 17 | 139 | 3 | GO:0042613 | |
| GeneOntologyCellularComponent | endocytic vesicle membrane | 5.51e-04 | 212 | 139 | 7 | GO:0030666 | |
| GeneOntologyCellularComponent | MHC protein complex | 6.69e-04 | 26 | 139 | 3 | GO:0042611 | |
| GeneOntologyCellularComponent | COPII-coated ER to Golgi transport vesicle | 8.46e-04 | 110 | 139 | 5 | GO:0030134 | |
| GeneOntologyCellularComponent | ER to Golgi transport vesicle membrane | 8.73e-04 | 64 | 139 | 4 | GO:0012507 | |
| GeneOntologyCellularComponent | endocytic vesicle | FLNB CAMK2B CAMK2D CAMK2G HLA-DRB3 HLA-DRB4 HLA-DRB5 NOD2 SCARA5 | 1.09e-03 | 384 | 139 | 9 | GO:0030139 |
| Domain | CaMKII_AD | 1.37e-06 | 4 | 132 | 3 | PF08332 | |
| Domain | Ca/CaM-dep_prot_kinase-assoc | 1.37e-06 | 4 | 132 | 3 | IPR013543 | |
| Domain | Ig_E-set | 9.02e-06 | 104 | 132 | 7 | IPR014756 | |
| Domain | Aspartic_peptidase_N | 1.18e-05 | 7 | 132 | 3 | IPR012848 | |
| Domain | A1_Propeptide | 1.18e-05 | 7 | 132 | 3 | PF07966 | |
| Domain | MHC_II_b_N | 1.88e-05 | 8 | 132 | 3 | PD000328 | |
| Domain | MHC_II_b_N | 2.81e-05 | 9 | 132 | 3 | IPR000353 | |
| Domain | MHC_II_beta | 2.81e-05 | 9 | 132 | 3 | SM00921 | |
| Domain | MHC_II_beta | 2.81e-05 | 9 | 132 | 3 | PF00969 | |
| Domain | Aspartic_peptidase_A1 | 3.99e-05 | 10 | 132 | 3 | IPR001461 | |
| Domain | IG_FLMN | 3.99e-05 | 10 | 132 | 3 | SM00557 | |
| Domain | PEPTIDASE_A1 | 3.99e-05 | 10 | 132 | 3 | IPR033121 | |
| Domain | Asp | 3.99e-05 | 10 | 132 | 3 | PF00026 | |
| Domain | PEPTIDASE_A1 | 3.99e-05 | 10 | 132 | 3 | PS51767 | |
| Domain | Filamin | 5.46e-05 | 11 | 132 | 3 | PF00630 | |
| Domain | FILAMIN_REPEAT | 5.46e-05 | 11 | 132 | 3 | PS50194 | |
| Domain | Filamin/ABP280_rpt | 5.46e-05 | 11 | 132 | 3 | IPR001298 | |
| Domain | Filamin/ABP280_repeat-like | 5.46e-05 | 11 | 132 | 3 | IPR017868 | |
| Domain | - | 7.25e-05 | 12 | 132 | 3 | 2.40.70.10 | |
| Domain | ZU5 | 7.25e-05 | 12 | 132 | 3 | PF00791 | |
| Domain | ZU5_dom | 7.25e-05 | 12 | 132 | 3 | IPR000906 | |
| Domain | ASP_PROTEASE | 7.25e-05 | 12 | 132 | 3 | PS00141 | |
| Domain | - | 9.37e-05 | 13 | 132 | 3 | 3.10.450.50 | |
| Domain | Aspartic_peptidase_AS | 9.37e-05 | 13 | 132 | 3 | IPR001969 | |
| Domain | MHC_II_a/b_N | 1.19e-04 | 14 | 132 | 3 | IPR014745 | |
| Domain | - | 1.19e-04 | 14 | 132 | 3 | 3.10.320.10 | |
| Domain | NTF2-like_dom | 1.48e-04 | 15 | 132 | 3 | IPR032710 | |
| Domain | Ago_hook | 1.48e-04 | 3 | 132 | 2 | PF10427 | |
| Domain | TNRC6_PABC-bd | 1.48e-04 | 3 | 132 | 2 | IPR032226 | |
| Domain | Argonaute_hook_dom | 1.48e-04 | 3 | 132 | 2 | IPR019486 | |
| Domain | A-amylase_C | 1.48e-04 | 3 | 132 | 2 | IPR031319 | |
| Domain | TNRC6-PABC_bdg | 1.48e-04 | 3 | 132 | 2 | PF16608 | |
| Domain | Peptidase_aspartic_dom | 2.18e-04 | 17 | 132 | 3 | IPR021109 | |
| Domain | Alpha_amylase | 2.95e-04 | 4 | 132 | 2 | IPR006046 | |
| Domain | Aamy_C | 2.95e-04 | 4 | 132 | 2 | SM00632 | |
| Domain | SRCR | 4.18e-04 | 21 | 132 | 3 | PF00530 | |
| Domain | Quino_amine_DH_bsu | 4.82e-04 | 22 | 132 | 3 | IPR011044 | |
| Domain | Alpha-amylase_C | 4.89e-04 | 5 | 132 | 2 | PF02806 | |
| Domain | EXOC3/Sec6 | 4.89e-04 | 5 | 132 | 2 | IPR010326 | |
| Domain | A-amylase/branching_C | 4.89e-04 | 5 | 132 | 2 | IPR006048 | |
| Domain | Protocadherin | 4.89e-04 | 5 | 132 | 2 | PF08374 | |
| Domain | UPA | 4.89e-04 | 5 | 132 | 2 | PF17217 | |
| Domain | Sec6 | 4.89e-04 | 5 | 132 | 2 | PF06046 | |
| Domain | UPA | 4.89e-04 | 5 | 132 | 2 | IPR033772 | |
| Domain | Protocadherin | 4.89e-04 | 5 | 132 | 2 | IPR013585 | |
| Domain | NACHT | 5.51e-04 | 23 | 132 | 3 | PS50837 | |
| Domain | NACHT_NTPase | 5.51e-04 | 23 | 132 | 3 | IPR007111 | |
| Domain | - | 7.08e-04 | 25 | 132 | 3 | 3.10.250.10 | |
| Domain | SR | 7.08e-04 | 25 | 132 | 3 | SM00202 | |
| Domain | Glyco_hydro_13 | 7.30e-04 | 6 | 132 | 2 | IPR015902 | |
| Domain | SRCR-like_dom | 7.97e-04 | 26 | 132 | 3 | IPR017448 | |
| Domain | SRCR_1 | 7.97e-04 | 26 | 132 | 3 | PS00420 | |
| Domain | SRCR_2 | 7.97e-04 | 26 | 132 | 3 | PS50287 | |
| Domain | - | FLNB TRIM2 HLA-DRB3 HLA-DRB4 HLA-DRB5 NFASC TGM6 TRIM3 UNC5A PTPRF UNC5C PLXNA1 PLXNA2 | 8.47e-04 | 663 | 132 | 13 | 2.60.40.10 |
| Domain | SRCR | 8.91e-04 | 27 | 132 | 3 | IPR001190 | |
| Domain | Arm_3 | 1.02e-03 | 7 | 132 | 2 | PF16186 | |
| Domain | Glyco_hydro_13_cat_dom | 1.02e-03 | 7 | 132 | 2 | IPR006047 | |
| Domain | Importing_su_alpha | 1.02e-03 | 7 | 132 | 2 | IPR024931 | |
| Domain | IBB | 1.02e-03 | 7 | 132 | 2 | PF01749 | |
| Domain | Alpha-amylase | 1.02e-03 | 7 | 132 | 2 | PF00128 | |
| Domain | Aamy | 1.02e-03 | 7 | 132 | 2 | SM00642 | |
| Domain | Arm_3 | 1.02e-03 | 7 | 132 | 2 | IPR032413 | |
| Domain | IBB | 1.35e-03 | 8 | 132 | 2 | PS51214 | |
| Domain | Ca/CaM-dep_Ca-dep_prot_Kinase | 1.44e-03 | 69 | 132 | 4 | IPR020636 | |
| Domain | Ig-like_fold | FLNB TRIM2 HLA-DRB3 HLA-DRB4 HLA-DRB5 NFASC TGM6 TRIM3 UNC5A PTPRF UNC5C PLXNA1 PLXNA2 | 1.49e-03 | 706 | 132 | 13 | IPR013783 |
| Domain | Plexin_cytopl | 1.73e-03 | 9 | 132 | 2 | PF08337 | |
| Domain | NHL_repeat_subgr | 1.73e-03 | 9 | 132 | 2 | IPR013017 | |
| Domain | Importin-a_IBB | 1.73e-03 | 9 | 132 | 2 | IPR002652 | |
| Domain | ZU5 | 1.73e-03 | 9 | 132 | 2 | SM00218 | |
| Domain | Plexin_cytoplasmic_RasGAP_dom | 1.73e-03 | 9 | 132 | 2 | IPR013548 | |
| Domain | Plexin | 1.73e-03 | 9 | 132 | 2 | IPR031148 | |
| Domain | - | 1.91e-03 | 35 | 132 | 3 | 3.20.20.80 | |
| Domain | NHL_repeat | 2.15e-03 | 10 | 132 | 2 | IPR001258 | |
| Domain | NHL | 2.15e-03 | 10 | 132 | 2 | PF01436 | |
| Domain | ZU5 | 2.15e-03 | 10 | 132 | 2 | PS51145 | |
| Domain | Glyco_hydro_catalytic_dom | 2.43e-03 | 38 | 132 | 3 | IPR013781 | |
| Domain | MHC_I/II-like_Ag-recog | 2.43e-03 | 38 | 132 | 3 | IPR011162 | |
| Domain | - | 3.55e-03 | 207 | 132 | 6 | 1.25.40.10 | |
| Domain | NHL | 3.67e-03 | 13 | 132 | 2 | PS51125 | |
| Domain | TPR_1 | 3.81e-03 | 90 | 132 | 4 | IPR001440 | |
| Domain | TPR_1 | 3.81e-03 | 90 | 132 | 4 | PF00515 | |
| Domain | - | 4.27e-03 | 14 | 132 | 2 | 2.60.40.1180 | |
| Domain | - | 4.28e-03 | 93 | 132 | 4 | 1.10.533.10 | |
| Domain | - | 4.62e-03 | 95 | 132 | 4 | 2.60.120.200 | |
| Domain | Bbox_C | 4.90e-03 | 15 | 132 | 2 | IPR003649 | |
| Domain | BBC | 4.90e-03 | 15 | 132 | 2 | SM00502 | |
| Domain | Glyco_hydro_b | 4.90e-03 | 15 | 132 | 2 | IPR013780 | |
| Domain | WD40_repeat_dom | 5.21e-03 | 297 | 132 | 7 | IPR017986 | |
| Domain | DEATH-like_dom | 5.35e-03 | 99 | 132 | 4 | IPR011029 | |
| Domain | VWF_A | 5.35e-03 | 99 | 132 | 4 | IPR002035 | |
| Domain | Glycoside_hydrolase_SF | 6.25e-03 | 53 | 132 | 3 | IPR017853 | |
| Domain | TPR_8 | 6.25e-03 | 53 | 132 | 3 | PF13181 | |
| Domain | TPR-like_helical_dom | 6.28e-03 | 233 | 132 | 6 | IPR011990 | |
| Domain | TPR_REGION | 6.37e-03 | 165 | 132 | 5 | PS50293 | |
| Domain | TPR | 6.37e-03 | 165 | 132 | 5 | PS50005 | |
| Domain | EGF | 6.54e-03 | 235 | 132 | 6 | SM00181 | |
| Domain | C1-set | 6.58e-03 | 54 | 132 | 3 | PF07654 | |
| Pathway | REACTOME_INTERFERON_SIGNALING | KPNA5 FLNB RANBP2 TRIM2 CAMK2B CAMK2D CAMK2G HLA-DRB3 HLA-DRB4 HLA-DRB5 TRIM3 IKBKB NUP160 KPNA1 | 9.71e-09 | 273 | 102 | 14 | M983 |
| Pathway | REACTOME_INTERFERON_GAMMA_SIGNALING | 5.24e-07 | 98 | 102 | 8 | M965 | |
| Pathway | REACTOME_PHASE_0_RAPID_DEPOLARISATION | 3.10e-06 | 32 | 102 | 5 | M27455 | |
| Pathway | REACTOME_REGULATION_OF_MECP2_EXPRESSION_AND_ACTIVITY | 3.10e-06 | 32 | 102 | 5 | M27900 | |
| Pathway | REACTOME_RAS_ACTIVATION_UPON_CA2_INFLUX_THROUGH_NMDA_RECEPTOR | 1.15e-05 | 20 | 102 | 4 | M17670 | |
| Pathway | REACTOME_UNBLOCKING_OF_NMDA_RECEPTORS_GLUTAMATE_BINDING_AND_ACTIVATION | 1.41e-05 | 21 | 102 | 4 | M838 | |
| Pathway | REACTOME_NEGATIVE_REGULATION_OF_NMDA_RECEPTOR_MEDIATED_NEURONAL_TRANSMISSION | 1.41e-05 | 21 | 102 | 4 | M27944 | |
| Pathway | REACTOME_ASSEMBLY_AND_CELL_SURFACE_PRESENTATION_OF_NMDA_RECEPTORS | 1.56e-05 | 44 | 102 | 5 | M27934 | |
| Pathway | REACTOME_UNBLOCKING_OF_NMDA_RECEPTORS_GLUTAMATE_BINDING_AND_ACTIVATION | 1.71e-05 | 22 | 102 | 4 | MM15104 | |
| Pathway | REACTOME_LONG_TERM_POTENTIATION | 2.06e-05 | 23 | 102 | 4 | M27949 | |
| Pathway | WP_NOCGMPPKG_MEDIATED_NEUROPROTECTION | 2.17e-05 | 47 | 102 | 5 | M39531 | |
| Pathway | REACTOME_CAMK_IV_MEDIATED_PHOSPHORYLATION_OF_CREB | 4.25e-05 | 10 | 102 | 3 | M26910 | |
| Pathway | REACTOME_CREB1_PHOSPHORYLATION_THROUGH_NMDA_RECEPTOR_MEDIATED_ACTIVATION_OF_RAS_SIGNALING | 4.63e-05 | 28 | 102 | 4 | M837 | |
| Pathway | BIOCARTA_BBCELL_PATHWAY | 5.82e-05 | 11 | 102 | 3 | M22030 | |
| Pathway | BIOCARTA_EOSINOPHILS_PATHWAY | 5.82e-05 | 11 | 102 | 3 | M22048 | |
| Pathway | WP_GASTRIC_ACID_PRODUCTION | 5.82e-05 | 11 | 102 | 3 | M39726 | |
| Pathway | WP_DISRUPTION_OF_POSTSYNAPTIC_SIGNALING_BY_CNV | 9.00e-05 | 33 | 102 | 4 | M39875 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_MECP2 | 9.05e-05 | 63 | 102 | 5 | M27862 | |
| Pathway | BIOCARTA_IL5_PATHWAY | 9.98e-05 | 13 | 102 | 3 | M18928 | |
| Pathway | REACTOME_MUSCLE_CONTRACTION | 1.11e-04 | 203 | 102 | 8 | M5485 | |
| Pathway | REACTOME_ACTIVATION_OF_NMDA_RECEPTORS_AND_POSTSYNAPTIC_EVENTS | 1.14e-04 | 35 | 102 | 4 | MM15109 | |
| Pathway | BIOCARTA_MHC_PATHWAY | 1.26e-04 | 14 | 102 | 3 | M22023 | |
| Pathway | KEGG_MEDICUS_VARIANT_AMPLIFIED_EGFR_TO_PLCG_CAMK_SIGNALING_PATHWAY | 1.26e-04 | 14 | 102 | 3 | M47386 | |
| Pathway | KEGG_MEDICUS_VARIANT_AMPLIFIED_PDGFR_TO_PLCG_CAMK_SIGNALING_PATHWAY | 1.26e-04 | 14 | 102 | 3 | M47388 | |
| Pathway | BIOCARTA_TCRA_PATHWAY | 1.26e-04 | 14 | 102 | 3 | M10765 | |
| Pathway | BIOCARTA_BLYMPHOCYTE_PATHWAY | 1.26e-04 | 14 | 102 | 3 | M1473 | |
| Pathway | REACTOME_CA_DEPENDENT_EVENTS | 1.42e-04 | 37 | 102 | 4 | M749 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EGF_EGFR_PLCG_CAMK_SIGNALING_PATHWAY | 1.57e-04 | 15 | 102 | 3 | M47385 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HTLV_1_TAX_TO_NFY_MEDIATED_TRANSCRIPTION | 1.57e-04 | 15 | 102 | 3 | M47588 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ANTIGEN_PROCESSING_AND_PRESENTATION_BY_MHC_CLASS_II_MOLECULES | 1.57e-04 | 15 | 102 | 3 | M47604 | |
| Pathway | BIOCARTA_ASBCELL_PATHWAY | 1.57e-04 | 15 | 102 | 3 | M7298 | |
| Pathway | REACTOME_ISG15_ANTIVIRAL_MECHANISM | 1.95e-04 | 74 | 102 | 5 | M48006 | |
| Pathway | WP_NONGENOMIC_ACTIONS_OF_125_DIHYDROXYVITAMIN_D3 | 2.08e-04 | 75 | 102 | 5 | M39568 | |
| Pathway | REACTOME_NS1_MEDIATED_EFFECTS_ON_HOST_PATHWAYS | 2.13e-04 | 41 | 102 | 4 | M29574 | |
| Pathway | REACTOME_DAG_AND_IP3_SIGNALING | 2.13e-04 | 41 | 102 | 4 | M512 | |
| Pathway | KEGG_MEDICUS_REFERENCE_PDGF_PDGFR_PLCG_CAMK_SIGNALING_PATHWAY | 2.32e-04 | 17 | 102 | 3 | M47387 | |
| Pathway | WP_RENINANGIOTENSINALDOSTERONE_SYSTEM_RAAS | 2.81e-04 | 44 | 102 | 4 | M39845 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CA2_CAM_CAMK_SIGNALING_PATHWAY | 3.28e-04 | 19 | 102 | 3 | M47957 | |
| Pathway | REACTOME_INTERFERON_GAMMA_SIGNALING | 3.28e-04 | 19 | 102 | 3 | MM15473 | |
| Pathway | REACTOME_CARDIAC_CONDUCTION | 3.58e-04 | 130 | 102 | 6 | M27454 | |
| Pathway | KEGG_CELL_ADHESION_MOLECULES_CAMS | 4.04e-04 | 133 | 102 | 6 | M16476 | |
| Pathway | KEGG_HEMATOPOIETIC_CELL_LINEAGE | 4.15e-04 | 87 | 102 | 5 | M6856 | |
| Pathway | REACTOME_GENE_SILENCING_BY_RNA | 4.26e-04 | 49 | 102 | 4 | MM14837 | |
| Pathway | REACTOME_INTERFERON_SIGNALING | 4.92e-04 | 138 | 102 | 6 | MM15635 | |
| Pathway | BIOCARTA_CSK_PATHWAY | 5.12e-04 | 22 | 102 | 3 | M6327 | |
| Pathway | BIOCARTA_CTLA4_PATHWAY | 5.12e-04 | 22 | 102 | 3 | M1467 | |
| Pathway | REACTOME_CYTOKINE_SIGNALING_IN_IMMUNE_SYSTEM | KPNA5 FLNB RANBP2 TRIM2 CAMK2B CAMK2D CAMK2G HLA-DRB3 HLA-DRB4 HLA-DRB5 TRIM3 NOD2 IKBKB NUP160 KPNA1 | 5.31e-04 | 789 | 102 | 15 | M1060 |
| Pathway | REACTOME_CELLULAR_RESPONSE_TO_HEAT_STRESS | 5.37e-04 | 92 | 102 | 5 | MM14951 | |
| Pathway | BIOCARTA_TH1TH2_PATHWAY | 5.86e-04 | 23 | 102 | 3 | M6705 | |
| Pathway | REACTOME_HSF1_DEPENDENT_TRANSACTIVATION | 5.86e-04 | 23 | 102 | 3 | MM14953 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_ATP2B3_TO_ANGIOTENSIN_ALDOSTERONE_SIGNALING_PATHWAY | 5.86e-04 | 23 | 102 | 3 | M47512 | |
| Pathway | REACTOME_ACTIVATION_OF_NMDA_RECEPTORS_AND_POSTSYNAPTIC_EVENTS | 5.93e-04 | 94 | 102 | 5 | M2843 | |
| Pathway | REACTOME_G_PROTEIN_MEDIATED_EVENTS | 6.19e-04 | 54 | 102 | 4 | M26911 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_CACNA1D_H_TO_ANGIOTENSIN_ALDOSTERONE_SIGNALING_PATHWAY | 6.67e-04 | 24 | 102 | 3 | M47509 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_KCNJ5_TO_ANGIOTENSIN_ALDOSTERONE_SIGNALING_PATHWAY | 7.53e-04 | 25 | 102 | 3 | M47510 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_ATP1A1_TO_ANGIOTENSIN_ALDOSTERONE_SIGNALING_PATHWAY | 7.53e-04 | 25 | 102 | 3 | M47511 | |
| Pathway | REACTOME_POST_TRANSCRIPTIONAL_SILENCING_BY_SMALL_RNAS | 7.63e-04 | 6 | 102 | 2 | MM15083 | |
| Pathway | REACTOME_ANTIVIRAL_MECHANISM_BY_IFN_STIMULATED_GENES | 7.91e-04 | 151 | 102 | 6 | M550 | |
| Pathway | REACTOME_CELLULAR_RESPONSE_TO_HEAT_STRESS | 8.22e-04 | 101 | 102 | 5 | M27253 | |
| Pathway | REACTOME_PD_1_SIGNALING | 1.06e-03 | 28 | 102 | 3 | M18810 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ANGIOTENSIN_ALDOSTERONE_SIGNALING_PATHWAY | 1.06e-03 | 28 | 102 | 3 | M47508 | |
| Pathway | REACTOME_NEUROFASCIN_INTERACTIONS | 1.06e-03 | 7 | 102 | 2 | M27380 | |
| Pathway | REACTOME_POST_TRANSCRIPTIONAL_SILENCING_BY_SMALL_RNAS | 1.06e-03 | 7 | 102 | 2 | M46421 | |
| Pathway | REACTOME_TRAFFICKING_OF_AMPA_RECEPTORS | 1.17e-03 | 29 | 102 | 3 | MM15028 | |
| Pathway | BIOCARTA_INFLAM_PATHWAY | 1.17e-03 | 29 | 102 | 3 | M6910 | |
| Pathway | REACTOME_MUSCLE_CONTRACTION | 1.25e-03 | 165 | 102 | 6 | MM15026 | |
| Pathway | REACTOME_SURFACTANT_METABOLISM | 1.30e-03 | 30 | 102 | 3 | M27566 | |
| Pathway | KEGG_ASTHMA | 1.30e-03 | 30 | 102 | 3 | M13950 | |
| Pathway | REACTOME_NETRIN_MEDIATED_REPULSION_SIGNALS | 1.41e-03 | 8 | 102 | 2 | M27328 | |
| Pathway | REACTOME_CREB1_PHOSPHORYLATION_THROUGH_THE_ACTIVATION_OF_CAMKII_CAMKK_CAMKIV_CASCASDE | 1.41e-03 | 8 | 102 | 2 | M10546 | |
| Pathway | REACTOME_DIGESTION_OF_DIETARY_CARBOHYDRATE | 1.41e-03 | 8 | 102 | 2 | MM14717 | |
| Pathway | REACTOME_TRAFFICKING_OF_AMPA_RECEPTORS | 1.43e-03 | 31 | 102 | 3 | M7223 | |
| Pathway | REACTOME_SEMA3A_PLEXIN_REPULSION_SIGNALING_BY_INHIBITING_INTEGRIN_ADHESION | 1.81e-03 | 9 | 102 | 2 | MM15030 | |
| Pathway | KEGG_MEDICUS_REFERENCE_NOD_NFKB_SIGNALING_PATHWAY | 1.81e-03 | 9 | 102 | 2 | M47652 | |
| Pathway | KEGG_MEDICUS_REFERENCE_GLYCOGEN_DEGRADATION_AMYLASE_ | 1.81e-03 | 9 | 102 | 2 | M47622 | |
| Pathway | REACTOME_REGULATION_OF_PTEN_MRNA_TRANSLATION | 1.81e-03 | 9 | 102 | 2 | M27810 | |
| Pathway | REACTOME_REGULATION_OF_NPAS4_MRNA_TRANSLATION | 1.81e-03 | 9 | 102 | 2 | M46436 | |
| Pathway | REACTOME_RAF_ACTIVATION | 1.87e-03 | 34 | 102 | 3 | M27556 | |
| Pathway | REACTOME_RAF_ACTIVATION | 2.03e-03 | 35 | 102 | 3 | MM15271 | |
| Pathway | REACTOME_SARS_COV_2_ACTIVATES_MODULATES_INNATE_AND_ADAPTIVE_IMMUNE_RESPONSES | 2.20e-03 | 126 | 102 | 5 | M45009 | |
| Pathway | REACTOME_MHC_CLASS_II_ANTIGEN_PRESENTATION | 2.20e-03 | 126 | 102 | 5 | M705 | |
| Pathway | REACTOME_REGULATION_OF_CDH11_MRNA_TRANSLATION_BY_MICRORNAS | 2.25e-03 | 10 | 102 | 2 | M48013 | |
| Pathway | REACTOME_NR1H3_NR1H2_REGULATE_GENE_EXPRESSION_LINKED_TO_CHOLESTEROL_TRANSPORT_AND_EFFLUX | 2.39e-03 | 37 | 102 | 3 | M29790 | |
| Pathway | REACTOME_INTERACTIONS_OF_VPR_WITH_HOST_CELLULAR_PROTEINS | 2.39e-03 | 37 | 102 | 3 | M1029 | |
| Pathway | KEGG_ALLOGRAFT_REJECTION | 2.39e-03 | 37 | 102 | 3 | M18615 | |
| Pathway | REACTOME_HSF1_DEPENDENT_TRANSACTIVATION | 2.58e-03 | 38 | 102 | 3 | M27255 | |
| Pathway | REACTOME_DIGESTION_OF_DIETARY_CARBOHYDRATE | 2.73e-03 | 11 | 102 | 2 | M1091 | |
| Pathway | REACTOME_GENERATION_OF_SECOND_MESSENGER_MOLECULES | 2.78e-03 | 39 | 102 | 3 | M16523 | |
| Pathway | REACTOME_NERVOUS_SYSTEM_DEVELOPMENT | 2.85e-03 | 261 | 102 | 7 | MM15676 | |
| Pathway | REACTOME_NERVOUS_SYSTEM_DEVELOPMENT | SCN11A RELN NFASC ITGA2 ADGRV1 GFRA1 UNC5A UNC5C PLXNA1 SDCBP PLXNA2 | 2.92e-03 | 575 | 102 | 11 | M29853 |
| Pathway | REACTOME_NEURONAL_SYSTEM | 2.92e-03 | 411 | 102 | 9 | M735 | |
| Pathway | REACTOME_NEURONAL_SYSTEM | 2.96e-03 | 335 | 102 | 8 | MM14503 | |
| Pathway | PID_IFNG_PATHWAY | 2.99e-03 | 40 | 102 | 3 | M161 | |
| Pathway | KEGG_GRAFT_VERSUS_HOST_DISEASE | 3.21e-03 | 41 | 102 | 3 | M13519 | |
| Pathway | WP_NUCLEOTIDEBINDING_OLIGOMERIZATION_DOMAIN_NOD_PATHWAY | 3.21e-03 | 41 | 102 | 3 | M39698 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_SMALL_RNAS | 3.21e-03 | 41 | 102 | 3 | MM15200 | |
| Pathway | KEGG_TYPE_I_DIABETES_MELLITUS | 3.68e-03 | 43 | 102 | 3 | M12617 | |
| Pathway | REACTOME_REGULATION_OF_NPAS4_GENE_EXPRESSION | 3.84e-03 | 13 | 102 | 2 | M46434 | |
| Pathway | REACTOME_OPIOID_SIGNALLING | 4.10e-03 | 90 | 102 | 4 | M6467 | |
| Pathway | REACTOME_SIGNALING_BY_MODERATE_KINASE_ACTIVITY_BRAF_MUTANTS | 4.19e-03 | 45 | 102 | 3 | M27623 | |
| Pubmed | 6.52e-08 | 3 | 141 | 3 | 7926498 | ||
| Pubmed | 6.52e-08 | 3 | 141 | 3 | 9561228 | ||
| Pubmed | 6.52e-08 | 3 | 141 | 3 | 21455714 | ||
| Pubmed | 6.52e-08 | 3 | 141 | 3 | 19800305 | ||
| Pubmed | 6.52e-08 | 3 | 141 | 3 | 24170207 | ||
| Pubmed | Relationships between the human pepsinogen DNA and protein polymorphisms. | 6.52e-08 | 3 | 141 | 3 | 3014868 | |
| Pubmed | The ratio of pepsinogen A to pepsinogen C: a sensitive test for atrophic gastritis. | 6.52e-08 | 3 | 141 | 3 | 2799289 | |
| Pubmed | 6.52e-08 | 3 | 141 | 3 | 19872561 | ||
| Pubmed | Human pepsinogen A (PGA): an informative gene complex located at 11q13. | 6.52e-08 | 3 | 141 | 3 | 1968039 | |
| Pubmed | Diversity associated with the second expressed HLA-DRB locus in the human population. | 6.52e-08 | 3 | 141 | 3 | 9162096 | |
| Pubmed | 6.52e-08 | 3 | 141 | 3 | 8053437 | ||
| Pubmed | Family and population studies on the human pepsinogen A multigene family. | 6.52e-08 | 3 | 141 | 3 | 2566575 | |
| Pubmed | Immunoblot technique to visualise serum pepsinogen A isozymogen patterns. | 6.52e-08 | 3 | 141 | 3 | 2229438 | |
| Pubmed | 6.52e-08 | 3 | 141 | 3 | 25314140 | ||
| Pubmed | Validation of the pepsinogen test method for gastric cancer screening using a follow-up study. | 6.52e-08 | 3 | 141 | 3 | 19890696 | |
| Pubmed | 6.52e-08 | 3 | 141 | 3 | 22531795 | ||
| Pubmed | Diagnostic value of serum pepsinogen C in patients with raised serum concentrations of pepsinogen A. | 6.52e-08 | 3 | 141 | 3 | 8244094 | |
| Pubmed | 6.52e-08 | 3 | 141 | 3 | 21407214 | ||
| Pubmed | 6.52e-08 | 3 | 141 | 3 | 6774973 | ||
| Pubmed | 6.52e-08 | 3 | 141 | 3 | 6300126 | ||
| Pubmed | Pepsinogen I/II ratio is related to glucose, triacylglycerol, and uric acid levels. | 6.52e-08 | 3 | 141 | 3 | 22304859 | |
| Pubmed | 6.52e-08 | 3 | 141 | 3 | 24004680 | ||
| Pubmed | 6.52e-08 | 3 | 141 | 3 | 8038355 | ||
| Pubmed | Human pepsinogen A isozymogen patterns in serum and gastric mucosa. | 6.52e-08 | 3 | 141 | 3 | 2227273 | |
| Pubmed | 6.52e-08 | 3 | 141 | 3 | 23034090 | ||
| Pubmed | 6.52e-08 | 3 | 141 | 3 | 24125879 | ||
| Pubmed | 6.52e-08 | 3 | 141 | 3 | 8751234 | ||
| Pubmed | Enzyme-linked immunosorbent assay and radioimmunoassay of serum pepsinogen A. | 6.52e-08 | 3 | 141 | 3 | 3554488 | |
| Pubmed | 6.52e-08 | 3 | 141 | 3 | 23521833 | ||
| Pubmed | 6.52e-08 | 3 | 141 | 3 | 3017318 | ||
| Pubmed | Serum pepsinogen test for early detection of gastric cancer in a European country. | 6.52e-08 | 3 | 141 | 3 | 21989121 | |
| Pubmed | Identification of novel human tumor cell-specific CaMK-II variants. | 6.52e-08 | 3 | 141 | 3 | 9060999 | |
| Pubmed | 6.52e-08 | 3 | 141 | 3 | 10819240 | ||
| Pubmed | 6.52e-08 | 3 | 141 | 3 | 9855083 | ||
| Pubmed | 6.52e-08 | 3 | 141 | 3 | 9797498 | ||
| Pubmed | 6.52e-08 | 3 | 141 | 3 | 2478370 | ||
| Pubmed | 6.52e-08 | 3 | 141 | 3 | 3815274 | ||
| Pubmed | Pepsinogens: physiology, pharmacology pathophysiology and exercise. | 6.52e-08 | 3 | 141 | 3 | 10675278 | |
| Pubmed | 6.52e-08 | 3 | 141 | 3 | 3780036 | ||
| Pubmed | 6.52e-08 | 3 | 141 | 3 | 2901984 | ||
| Pubmed | Assignment of human pepsinogen A locus to the q12-pter region of chromosome 11. | 6.52e-08 | 3 | 141 | 3 | 3839486 | |
| Pubmed | 6.52e-08 | 3 | 141 | 3 | 20844140 | ||
| Pubmed | 6.52e-08 | 3 | 141 | 3 | 3467902 | ||
| Pubmed | 6.52e-08 | 3 | 141 | 3 | 4586732 | ||
| Pubmed | Genomic structure and evolution of the human pepsinogen A multigene family. | 6.52e-08 | 3 | 141 | 3 | 2892778 | |
| Pubmed | 6.52e-08 | 3 | 141 | 3 | 24383519 | ||
| Pubmed | 6.52e-08 | 3 | 141 | 3 | 1455184 | ||
| Pubmed | Hypomethylation and expression of pepsinogen A genes in the fundic mucosa of human stomach. | 6.52e-08 | 3 | 141 | 3 | 2831884 | |
| Pubmed | 6.52e-08 | 3 | 141 | 3 | 2032552 | ||
| Pubmed | 6.52e-08 | 3 | 141 | 3 | 1812762 | ||
| Pubmed | 6.52e-08 | 3 | 141 | 3 | 7923573 | ||
| Pubmed | 6.52e-08 | 3 | 141 | 3 | 9061458 | ||
| Pubmed | Ratio between serum IL-8 and pepsinogen A/C: a marker for atrophic body gastritis. | 6.52e-08 | 3 | 141 | 3 | 12588289 | |
| Pubmed | Gastric cancer detection using gastric juice pepsinogen and melanoma-associated gene RNA. | 6.52e-08 | 3 | 141 | 3 | 23897256 | |
| Pubmed | An aspartic proteinase expressed in the yolk sac and neonatal stomach of the mouse. | 6.52e-08 | 3 | 141 | 3 | 11566730 | |
| Pubmed | The effect of acute and chronic protein loading on urinary pepsinogen A excretion. | 6.52e-08 | 3 | 141 | 3 | 1956484 | |
| Pubmed | 6.52e-08 | 3 | 141 | 3 | 8540382 | ||
| Pubmed | 6.52e-08 | 3 | 141 | 3 | 22992016 | ||
| Pubmed | The role of serum pepsinogen in the detection of gastric cancer. | 6.52e-08 | 3 | 141 | 3 | 20981206 | |
| Pubmed | Gastric chief cell-specific transcription of the pepsinogen A gene. | 6.52e-08 | 3 | 141 | 3 | 8504820 | |
| Pubmed | Detection of pepsinogen in the neonatal lung and stomach by immunohistochemistry. | 6.52e-08 | 3 | 141 | 3 | 21970995 | |
| Pubmed | 6.52e-08 | 3 | 141 | 3 | 20428942 | ||
| Pubmed | 6.52e-08 | 3 | 141 | 3 | 9525001 | ||
| Pubmed | 6.52e-08 | 3 | 141 | 3 | 7886402 | ||
| Pubmed | 6.52e-08 | 3 | 141 | 3 | 17379991 | ||
| Pubmed | 6.52e-08 | 3 | 141 | 3 | 21547904 | ||
| Pubmed | A revised nomenclature for transcribed human endogenous retroviral loci. | 1.18e-07 | 94 | 141 | 7 | 21542922 | |
| Pubmed | 1.25e-07 | 12 | 141 | 4 | 8615909 | ||
| Pubmed | 1.25e-07 | 12 | 141 | 4 | 8665664 | ||
| Pubmed | 1.25e-07 | 12 | 141 | 4 | 12815021 | ||
| Pubmed | 2.51e-07 | 14 | 141 | 4 | 10373510 | ||
| Pubmed | Absence of layer-specific cadherin expression profiles in the neocortex of the reeler mutant mouse. | 2.51e-07 | 14 | 141 | 4 | 20847152 | |
| Pubmed | Allelic variation in the DR subregion of the human major histocompatibility complex. | 2.60e-07 | 4 | 141 | 3 | 3476943 | |
| Pubmed | 2.60e-07 | 4 | 141 | 3 | 10381553 | ||
| Pubmed | Serum pepsinogen I/II ratio is correlated with albuminuria in patients with type 2 diabetes. | 2.60e-07 | 4 | 141 | 3 | 23047493 | |
| Pubmed | 2.60e-07 | 4 | 141 | 3 | 26740600 | ||
| Pubmed | Pepsinogens, progastricsins, and prochymosins: structure, function, evolution, and development. | 2.60e-07 | 4 | 141 | 3 | 11915945 | |
| Pubmed | HLA-DRB alleles and systemic lupus erythematosus in Jamaicans. | 2.60e-07 | 4 | 141 | 3 | 12144077 | |
| Pubmed | 2.60e-07 | 4 | 141 | 3 | 8322031 | ||
| Pubmed | 2.60e-07 | 4 | 141 | 3 | 18520346 | ||
| Pubmed | Transcription factor SOX2 up-regulates stomach-specific pepsinogen A gene expression. | 2.60e-07 | 4 | 141 | 3 | 17136346 | |
| Pubmed | 2.60e-07 | 4 | 141 | 3 | 12698190 | ||
| Pubmed | Cadmium activates CaMK-II and initiates CaMK-II-dependent apoptosis in mesangial cells. | 2.60e-07 | 4 | 141 | 3 | 17367784 | |
| Pubmed | 2.60e-07 | 4 | 141 | 3 | 11889801 | ||
| Pubmed | The NMDA receptor is coupled to the ERK pathway by a direct interaction between NR2B and RasGRF1. | 3.41e-07 | 15 | 141 | 4 | 14622581 | |
| Pubmed | 3.41e-07 | 15 | 141 | 4 | 9481670 | ||
| Pubmed | In-depth proteomic analyses of exosomes isolated from expressed prostatic secretions in urine. | A2M FLNB PGA4 FAT4 AMY2A AMY2B ANPEP CETP ACTN2 ACE PGA5 ITFG1 FCGBP SCPEP1 DNASE2 SDCBP PGA3 CPNE7 | 3.67e-07 | 1070 | 141 | 18 | 23533145 |
| Pubmed | 6.48e-07 | 5 | 141 | 3 | 11013247 | ||
| Pubmed | Quantitation of HERV-K env gene expression and splicing in human breast cancer. | 6.48e-07 | 5 | 141 | 3 | 12629516 | |
| Pubmed | 6.48e-07 | 5 | 141 | 3 | 17910142 | ||
| Pubmed | 6.48e-07 | 5 | 141 | 3 | 21209221 | ||
| Pubmed | 6.48e-07 | 5 | 141 | 3 | 14722083 | ||
| Pubmed | 6.48e-07 | 5 | 141 | 3 | 16973583 | ||
| Pubmed | Genetic variability in HIV-1 gp120 affects interactions with HLA molecules and T cell receptor. | 6.48e-07 | 5 | 141 | 3 | 1970352 | |
| Pubmed | 6.48e-07 | 5 | 141 | 3 | 7645219 | ||
| Pubmed | 6.48e-07 | 5 | 141 | 3 | 12392858 | ||
| Pubmed | 6.48e-07 | 5 | 141 | 3 | 12209103 | ||
| Pubmed | HLA-DQA is associated with abdominal aortic aneurysms in the Belgian population. | 6.48e-07 | 5 | 141 | 3 | 17182961 | |
| Pubmed | 6.48e-07 | 5 | 141 | 3 | 18218981 | ||
| Pubmed | 6.48e-07 | 5 | 141 | 3 | 11782380 | ||
| Interaction | ZNF843 interactions | 1.88e-06 | 14 | 136 | 4 | int:ZNF843 | |
| Interaction | SCGB1D1 interactions | 3.38e-06 | 133 | 136 | 8 | int:SCGB1D1 | |
| Interaction | CIBAR2 interactions | 1.03e-05 | 7 | 136 | 3 | int:CIBAR2 | |
| Cytoband | 1q32.2 | 7.69e-05 | 27 | 140 | 3 | 1q32.2 | |
| Cytoband | 1q42-q43 | 1.92e-04 | 7 | 140 | 2 | 1q42-q43 | |
| GeneFamily | Tetratricopeptide repeat domain containing|Bardet-Biedl syndrome associated|BBSome | 2.59e-04 | 115 | 89 | 5 | 769 | |
| GeneFamily | Plexins | 8.43e-04 | 9 | 89 | 2 | 683 | |
| GeneFamily | C1-set domain containing | 1.15e-03 | 42 | 89 | 3 | 591 | |
| GeneFamily | Histocompatibility complex|C1-set domain containing | 1.32e-03 | 44 | 89 | 3 | 588 | |
| GeneFamily | Non-clustered protocadherins | 1.53e-03 | 12 | 89 | 2 | 21 | |
| GeneFamily | Cadherin related | 3.11e-03 | 17 | 89 | 2 | 24 | |
| GeneFamily | Armadillo repeat containing|Importins | 3.48e-03 | 18 | 89 | 2 | 596 | |
| Coexpression | SOBOLEV_PBMC_PANDEMRIX_AGE_18_64YO_1DY_UP | 3.65e-06 | 21 | 134 | 4 | M41167 | |
| Coexpression | FOURATI_BLOOD_TWINRIX_AGE_25_83YO_RESPONDERS_VS_POOR_RESPONDERS_0DY_DN | PGA4 DMXL2 GLB1L3 HLA-DRB4 UBR4 EMC9 TEP1 PGA5 UNC5A BAZ2A LOXL4 RCOR3 UTY PGA3 CFAP46 | 6.72e-06 | 746 | 134 | 15 | M40863 |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.22e-08 | 178 | 132 | 8 | a0ab20c588e7d43d0320d4779d9ab95c1c86e297 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.03e-08 | 184 | 132 | 8 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.03e-08 | 184 | 132 | 8 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.03e-08 | 184 | 132 | 8 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.03e-07 | 190 | 132 | 8 | 2306aa9dbeaef3be8484a5b236605de23cd75d4c | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.03e-07 | 190 | 132 | 8 | 1f83f7f24288a3b9ab33c2e113e845dba96adc8a | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.25e-07 | 195 | 132 | 8 | 803f714d91f2d97ecbee8c15a5139fd9310f66c7 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.25e-07 | 195 | 132 | 8 | 4f70157d42a16ff0259bc24a62803c4df4285c44 | |
| ToppCell | LPS_IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.36e-07 | 197 | 132 | 8 | b94645d57efe8d9e032bffb8c89af1f425c6421e | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_submucosal-gland|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.41e-07 | 198 | 132 | 8 | fab3135f03cf23a9f04f0eed543a9dc181f39f5f | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_submucosal-gland-SMG_Duct|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.52e-07 | 200 | 132 | 8 | b992eeddee38e6fe3564e9b1850f6b20b89bf47d | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Myeloid-Dendritic-conventional_dendritic_cell-DC_c1-CLEC9A|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.13e-07 | 155 | 132 | 7 | d76a0f99ec35560d18820f9c92b69364ef2250e3 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.33e-07 | 172 | 132 | 7 | 1ef243bce63d841c25e4b74d029d1377f84bcc3d | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.33e-07 | 172 | 132 | 7 | ab1c81be29f93ca8920c6ab5ab92f497a9256d3f | |
| ToppCell | severe_influenza-pDC|severe_influenza / disease group, cell group and cell class (v2) | 9.00e-07 | 174 | 132 | 7 | d8d2ded5812ed3b3db4109585714a6513c13326a | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-kidney_interstitial_fibroblast_5|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.05e-06 | 178 | 132 | 7 | d4ecb84e9b1f4ec49c519321156aa10f9bd34cce | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-kidney_interstitial_fibroblast_5|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.31e-06 | 184 | 132 | 7 | c5436a8e45f471b8d1301abbe9c7879204537f52 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.56e-06 | 189 | 132 | 7 | 71397e993a77d70b2eeede240bdfc7660b558987 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.56e-06 | 189 | 132 | 7 | 4eea4759520c312bd17a681034d8074e47093d2b | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.68e-06 | 191 | 132 | 7 | a58c75e9580139fb370b498d95660f10f3a2a27b | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.74e-06 | 192 | 132 | 7 | 9093a9e94a25682d109a7f6edc256a25a61103a0 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.74e-06 | 192 | 132 | 7 | 9ed5d49621ec1aa01716dc369bba1450b5f015f5 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_alveolar-distal|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.74e-06 | 192 | 132 | 7 | b7c01e12b3e9be960a741b08835f1dfff65d0d47 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.80e-06 | 193 | 132 | 7 | f1199518c3626fd29bfce65070dd21a660671213 | |
| ToppCell | NS-moderate-d_0-4|moderate / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.80e-06 | 193 | 132 | 7 | ea345d34440b25f65358a53dc72831998d1c3620 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.86e-06 | 194 | 132 | 7 | 81713e0409e8be695ba5dfdc67a997b33435dd9e | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.86e-06 | 194 | 132 | 7 | 90efdbd7f1c85fd7fd622b10340250b1d8fc1197 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.86e-06 | 194 | 132 | 7 | df82cce5ebeb73740b02cf816c6df82253cfd566 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.86e-06 | 194 | 132 | 7 | 627cffe2d448e74fc5df92e74e5b922a73304137 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Hematopoietic-Myeloid-MMP9+_Inflammatory_macrophage|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.92e-06 | 195 | 132 | 7 | 5a7c74f96f213c504abd65e751800da7e03e47d9 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.99e-06 | 196 | 132 | 7 | a12dd986df65c36f248cf10815c3b8b6238613b0 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.99e-06 | 196 | 132 | 7 | ba869f7a86f37fd6d84d6ad69baca0e0faaf5887 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.99e-06 | 196 | 132 | 7 | 30ad56d49000e4ddce73b4443b3994564bd1e2d6 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.99e-06 | 196 | 132 | 7 | 3e6803587d8566fd08cb8b290be3b6461743d79c | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.06e-06 | 197 | 132 | 7 | b349f8e96d61a4c296af64711e11fc44459a9413 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.06e-06 | 197 | 132 | 7 | 80e153790cef37b743e22a7370ff5b3a6abf147d | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.06e-06 | 197 | 132 | 7 | c2e390653d5dee7e731c1840cfdab41987dede9b | |
| ToppCell | Bronchial-10x5prime-Stromal-Fibroblastic-Fibro_immune_recruiting|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.20e-06 | 199 | 132 | 7 | 0cdbedf09ec72734b86ddab3fec562e066afed92 | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 2.28e-06 | 200 | 132 | 7 | e8db082aa4d0597500e4f16a5c0ea3e62c6c59ae | |
| ToppCell | Tracheal-10x5prime-Endothelial-Endothelia_vascular-VE_systemic_arterial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.28e-06 | 200 | 132 | 7 | 5ec31c1be6bcc4124e1489d136570f3de33cc2e9 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_hypoxia/MES-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.28e-06 | 200 | 132 | 7 | 851c57187db8bc91a393655bca5f13e787a723d4 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-4M-Neuronal-cortical_neurons_2|Organoid-4M / Sample Type, Dataset, Time_group, and Cell type. | 2.28e-06 | 200 | 132 | 7 | 0cb0755a101ec655359d051d6a8807408d727c55 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Myh8_Fibin|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 7.48e-06 | 157 | 132 | 6 | 741d79c10cb87fa7f14080c6fccb1553c3a20bad | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_prolif|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.04e-06 | 159 | 132 | 6 | 7ed659163f45e0c4df4782997c0786900c8186c8 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_medulla-lymphatic_endothelial_cell_of_renal_medulla|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 9.59e-06 | 164 | 132 | 6 | a784f47f67a5eda84d58ad7d9400e3978edbb487 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Endothelial-lymphatic_endothelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 9.59e-06 | 164 | 132 | 6 | 1a1795969673232191425dde84ab24ee6a98143f | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_medulla|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 9.59e-06 | 164 | 132 | 6 | 8f074940afdbda88a4b697a7ddc687e09a4b818b | |
| ToppCell | NS-critical-d_0-4-Epithelial-Secretory|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.14e-05 | 169 | 132 | 6 | aec97583b23112060437b619cb429dc32f29285f | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.22e-05 | 171 | 132 | 6 | 5d31fc9b60329d4ae3c77e4ca679359d9314397d | |
| ToppCell | mild_COVID-19-pDC|World / disease group, cell group and cell class (v2) | 1.26e-05 | 172 | 132 | 6 | dab2f1a05c7df58d9387b13271b3f1f1583f9ac3 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.43e-05 | 176 | 132 | 6 | b4a23d8d1414434adeb237a96f28c825f1aebd77 | |
| ToppCell | AT1-AT2_cells-IPF_04|World / lung cells shred on cell class, cell subclass, sample id | 1.43e-05 | 176 | 132 | 6 | f86832cfeff5b3cfffe4455c1b96a1420d48ba1e | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.43e-05 | 176 | 132 | 6 | 66c9c6b59030f67e8d746a9c6930e50923f2ded1 | |
| ToppCell | metastatic_Brain-B_lymphocytes-GrB-secreting_B_cells|B_lymphocytes / Location, Cell class and cell subclass | 1.48e-05 | 177 | 132 | 6 | 43e1d0d3cf8f0c02e67d91f8dd1761df23d59e07 | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway-Secretory/RAS|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.48e-05 | 177 | 132 | 6 | 779ba86f53650772755b52460be03f18bb204e55 | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway-Secretory/RAS-Secretory|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.48e-05 | 177 | 132 | 6 | 0f210cfb61b873c5fd77dc17eadf4d017306500e | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-kidney_interstitial_fibroblast_5|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.53e-05 | 178 | 132 | 6 | 78a0c6340001a77f5b2d890b6263f574af2e72da | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Myeloid-Dendritic-plasmacytoid_dendritic_cell|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.58e-05 | 179 | 132 | 6 | 124da6f882968dc0d05f3edd8f3b4d61617cc214 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Myeloid-Dendritic-plasmacytoid_dendritic_cell-DC_c4-LILRA4|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.58e-05 | 179 | 132 | 6 | edc5ef693dc4e7ea70717b77fb908fc784dce3a2 | |
| ToppCell | droplet-Marrow-BM-1m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.68e-05 | 181 | 132 | 6 | fb64da1dde37fe6ba7de2586cd58848ac1974f24 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.73e-05 | 182 | 132 | 6 | b7d532feb73167e05475855061b35a209583f44c | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.73e-05 | 182 | 132 | 6 | af65f0fc3f9e5d9ce69ee5faaf5b6cb7f8412e0c | |
| ToppCell | Children_(3_yrs)-Epithelial-lung_goblet_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.73e-05 | 182 | 132 | 6 | 3f1a666fe27dd7529c114539ed5f6b8ca585c875 | |
| ToppCell | Hippocampus-Neuronal-Inhibitory|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 1.73e-05 | 182 | 132 | 6 | b54ae650c04dfd0759c5f5e752b9bf684dd36516 | |
| ToppCell | COVID-19-Epithelial_cells-ECM-high_epithelial|COVID-19 / group, cell type (main and fine annotations) | 1.79e-05 | 183 | 132 | 6 | dc1d380bf7564f290256cb7108063d1bd2da732b | |
| ToppCell | RA-13._Vascular_Smooth_Muscle|World / Chamber and Cluster_Paper | 1.79e-05 | 183 | 132 | 6 | cae2ee08f985a6f005b4b8e959e465350315156a | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.84e-05 | 184 | 132 | 6 | e061e85c4bb19f49f6451ddd7a9077d7378ee365 | |
| ToppCell | Healthy_donor-pDC|Healthy_donor / disease group, cell group and cell class (v2) | 1.90e-05 | 185 | 132 | 6 | 7fbb55cbdb39bdecb6063c8ba9776ab06c2666e8 | |
| ToppCell | droplet-Lung-LUNG-30m-Endothelial-endothelial_cell_of_lymphatic_vessel|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.96e-05 | 186 | 132 | 6 | f23f21781a758541f59c06efa7739d26a03fb478 | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.96e-05 | 186 | 132 | 6 | 4e94158db52df41d71e67b02b9895a358eebee0f | |
| ToppCell | Myeloid-B_(Activated_Macrophage)|World / shred on cell class and cell subclass (v4) | 1.96e-05 | 186 | 132 | 6 | 33d731a7883d75e4e7db83b641cdb1e9a39938bf | |
| ToppCell | healthy_donor-Lymphocytic-Dendritic|healthy_donor / Disease condition, Lineage, Cell class and subclass | 1.96e-05 | 186 | 132 | 6 | 916f2aeea4989ba7a29e071e348a51010f010223 | |
| ToppCell | droplet-Lung-LUNG-30m-Endothelial-Lymphatic_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.96e-05 | 186 | 132 | 6 | 0de87109da9324c597fadf2eb782f0f158afe832 | |
| ToppCell | healthy_donor-Lymphocytic-Dendritic-pDC|healthy_donor / Disease condition, Lineage, Cell class and subclass | 1.96e-05 | 186 | 132 | 6 | 45f66619e45d590c7365a51782d4ac46b7d31fde | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.02e-05 | 187 | 132 | 6 | d591a3c216997663ab77710fed0d230ffc37e41a | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.02e-05 | 187 | 132 | 6 | d1dc8c9a2c2cd10c640257161a75e7730ec5bb41 | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.02e-05 | 187 | 132 | 6 | ac8e092b37e042975e2ee057d3f7c6821e58e8b5 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.02e-05 | 187 | 132 | 6 | 58d48128547ee3513d0bf7f78e61b76b1c472ca9 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum_-18m-Neuronal-interneuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.02e-05 | 187 | 132 | 6 | 1b2fdbfb1ce3f19795dfc4b1da5a94f4b057ec41 | |
| ToppCell | Healthy_donor-pDC|World / disease group, cell group and cell class (v2) | 2.02e-05 | 187 | 132 | 6 | aa2cc54487d3c5045ac0c93560944c5a55878e27 | |
| ToppCell | (0)_Myeloid-(011)_pDC|(0)_Myeloid / immune cells in Peripheral Blood (logTPM normalization) | 2.08e-05 | 188 | 132 | 6 | a81b5d840490d6a636fe168f8cff2c4984369f09 | |
| ToppCell | PBMC-Mild-Myeloid-pDC-pDC|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.08e-05 | 188 | 132 | 6 | 89411c4db3df5e1dc36cf8af4ffcc0abbecbe4df | |
| ToppCell | PBMC-Mild-Myeloid-pDC|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.08e-05 | 188 | 132 | 6 | de6a270b6e4fe09c39a52c296632d86ada98465b | |
| ToppCell | PBMC-Mild-Myeloid-pDC-pDC-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.08e-05 | 188 | 132 | 6 | 879054b780378ae05be68e597c77c931bf0ade03 | |
| ToppCell | PBMC-Mild-Myeloid-pDC|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.14e-05 | 189 | 132 | 6 | 209cae68d78c8f72479b169e27c3ff7e143adece | |
| ToppCell | PBMC-Mild-Myeloid-pDC-pDC-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.14e-05 | 189 | 132 | 6 | a9ad1fb12304541f909dd0eeac9b9eb28c31fd41 | |
| ToppCell | COVID-19_Mild-Myeloid-pDC|COVID-19_Mild / Disease group, lineage and cell class | 2.14e-05 | 189 | 132 | 6 | c6cfd6aa21c19f2c62d80218bbc924e14e82aada | |
| ToppCell | Adult|World / Lineage, Cell type, age group and donor | 2.14e-05 | 189 | 132 | 6 | 5cd285bfad973125d46d704fec18b21266a63379 | |
| ToppCell | PBMC-Mild-Myeloid-pDC-pDC|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.14e-05 | 189 | 132 | 6 | 98ca646231fbd5f29827c2dd31ac4503026bad7d | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.14e-05 | 189 | 132 | 6 | c734e5693808a0333139e87bd5be2597a9252afe | |
| ToppCell | COVID-19-kidney-AQP1+SLC14A1+EC|kidney / Disease (COVID-19 only), tissue and cell type | 2.21e-05 | 190 | 132 | 6 | 1519f34d31fe0817184c5865a0bc9f0cb479b1a4 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.21e-05 | 190 | 132 | 6 | 2e592323085ba9c019d678ac2a784462ab470ed9 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.21e-05 | 190 | 132 | 6 | 445952b70abffadb6ccc1ed4bbf61a88b06b73b3 | |
| ToppCell | COVID-19-Epithelial_cells-Airway_goblet|COVID-19 / group, cell type (main and fine annotations) | 2.21e-05 | 190 | 132 | 6 | 51ca9ef4df3220487152fcf684147730637c7cc1 | |
| ToppCell | PCW_05-06-Neuronal-Neuronal_postreplicative-neuro_neuronal_(6)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 2.27e-05 | 191 | 132 | 6 | 3a5081dc542ac6262acfe5f8084a86616fee8082 | |
| ToppCell | (011)_pDC|World / immune cells in Peripheral Blood (logTPM normalization) | 2.27e-05 | 191 | 132 | 6 | d82ac4f6d9863734e09bf3cb71c1354a49b66b4f | |
| ToppCell | (01)_Dendritic_cell|World / immune cells in Peripheral Blood (logTPM normalization) | 2.27e-05 | 191 | 132 | 6 | 1f4c8078e1a6cd14937c714330af608caced2acf | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.27e-05 | 191 | 132 | 6 | c54c420a94dc749ebc67fc64c5614663f4b9798d | |
| ToppCell | Myeloid-Myeloid-B_(Activated_Macrophage)|Myeloid / shred on cell class and cell subclass (v4) | 2.27e-05 | 191 | 132 | 6 | 7bf125249af1e8bb138ed4d999fdd74b03ab2447 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.27e-05 | 191 | 132 | 6 | 39092a0aff8097617820c59f5fea9ee2bb4f63a2 | |
| Disease | Alzheimer's Disease | 6.12e-06 | 101 | 131 | 6 | C0002395 | |
| Disease | Schizophrenia | RELN ABCA13 CAMK2B NFASC ACE GFRA1 SBNO2 SLC6A9 NRXN3 UNC5C NUFIP2 ERVK-8 PLXNA2 KPNA1 | 4.00e-05 | 883 | 131 | 14 | C0036341 |
| Disease | electrodermal activity measurement | 5.85e-05 | 3 | 131 | 2 | EFO_0006866 | |
| Disease | autosomal recessive limb-girdle muscular dystrophy type 2H (implicated_via_orthology) | 5.85e-05 | 3 | 131 | 2 | DOID:0110282 (implicated_via_orthology) | |
| Disease | autosomal recessive limb-girdle muscular dystrophy (implicated_via_orthology) | 5.85e-05 | 3 | 131 | 2 | DOID:0110274 (implicated_via_orthology) | |
| Disease | Acute Confusional Senile Dementia | 8.18e-05 | 99 | 131 | 5 | C0546126 | |
| Disease | Alzheimer's Disease, Focal Onset | 8.18e-05 | 99 | 131 | 5 | C0750900 | |
| Disease | Alzheimer Disease, Early Onset | 8.18e-05 | 99 | 131 | 5 | C0750901 | |
| Disease | Presenile dementia | 8.18e-05 | 99 | 131 | 5 | C0011265 | |
| Disease | Alzheimer Disease, Late Onset | 8.18e-05 | 99 | 131 | 5 | C0494463 | |
| Disease | Familial Alzheimer Disease (FAD) | 8.58e-05 | 100 | 131 | 5 | C0276496 | |
| Disease | focal segmental glomerulosclerosis 1 (implicated_via_orthology) | 1.94e-04 | 5 | 131 | 2 | DOID:0111128 (implicated_via_orthology) | |
| Disease | cholesteryl ester transfer protein measurement | 2.90e-04 | 6 | 131 | 2 | EFO_0009133 | |
| Disease | Alzheimer disease | 3.28e-04 | 485 | 131 | 9 | MONDO_0004975 | |
| Disease | heart conduction disease (implicated_via_orthology) | 3.86e-04 | 32 | 131 | 3 | DOID:10273 (implicated_via_orthology) | |
| Disease | colorectal adenocarcinoma (is_implicated_in) | 5.04e-04 | 35 | 131 | 3 | DOID:0050861 (is_implicated_in) | |
| Disease | Behcet's disease (is_implicated_in) | 5.49e-04 | 36 | 131 | 3 | DOID:13241 (is_implicated_in) | |
| Disease | alpha-amylase 1 measurement | 6.90e-04 | 9 | 131 | 2 | EFO_0801371 | |
| Disease | familial Mediterranean fever (is_implicated_in) | 6.90e-04 | 9 | 131 | 2 | DOID:2987 (is_implicated_in) | |
| Disease | epilepsy (implicated_via_orthology) | 8.22e-04 | 163 | 131 | 5 | DOID:1826 (implicated_via_orthology) | |
| Disease | aspirin-induced respiratory disease (is_implicated_in) | 1.05e-03 | 11 | 131 | 2 | DOID:0080822 (is_implicated_in) | |
| Disease | cervical carcinoma | 1.34e-03 | 182 | 131 | 5 | EFO_0001061 | |
| Disease | Bipolar Disorder | 1.35e-03 | 477 | 131 | 8 | C0005586 | |
| Disease | gamma-glutamylleucine measurement | 1.48e-03 | 13 | 131 | 2 | EFO_0021140 | |
| Disease | disease recurrence, colon carcinoma | 1.52e-03 | 51 | 131 | 3 | EFO_0004952, EFO_1001950 | |
| Disease | beta-amyloid 1-42 measurement, cerebrospinal fluid biomarker measurement | 1.72e-03 | 14 | 131 | 2 | EFO_0004670, EFO_0006794 | |
| Disease | response to TNF antagonist | 1.80e-03 | 54 | 131 | 3 | EFO_0004653 | |
| Disease | amyotrophic lateral sclerosis, age at onset | 1.98e-03 | 15 | 131 | 2 | EFO_0004847, MONDO_0004976 | |
| Disease | aspartate aminotransferase measurement | FLNB CUX2 ANPEP CACNA2D2 CETP HLA-DRB3 BAZ2A DEF6 LOXL4 NUP160 SDCBP | 2.37e-03 | 904 | 131 | 11 | EFO_0004736 |
| Disease | Psychoses, Substance-Induced | 2.55e-03 | 17 | 131 | 2 | C0033941 | |
| Disease | tuberculosis | 2.83e-03 | 216 | 131 | 5 | MONDO_0018076 | |
| Disease | attention deficit hyperactivity disorder, Cannabis use | 2.86e-03 | 18 | 131 | 2 | EFO_0003888, EFO_0007585 | |
| Disease | bitter alcoholic beverage consumption measurement | 2.97e-03 | 133 | 131 | 4 | EFO_0010092 | |
| Disease | osteoarthritis | 3.18e-03 | 222 | 131 | 5 | MONDO_0005178 | |
| Disease | juvenile dermatomyositis | 3.53e-03 | 20 | 131 | 2 | EFO_0000557 | |
| Disease | COVID-19 (is_implicated_in) | 3.89e-03 | 21 | 131 | 2 | DOID:0080600 (is_implicated_in) | |
| Disease | Psychoses, Drug | 3.89e-03 | 21 | 131 | 2 | C0033937 | |
| Disease | muscular dystrophy (implicated_via_orthology) | 3.89e-03 | 21 | 131 | 2 | DOID:9884 (implicated_via_orthology) | |
| Disease | cortical thickness | A2M FLNB RELN TNRC6B ADGRV1 FRMD4B VPS13D MALRD1 ALX1 PTPRF TNRC6A PLXNA2 | 4.05e-03 | 1113 | 131 | 12 | EFO_0004840 |
| Disease | Henoch-Schoenlein purpura | 4.26e-03 | 22 | 131 | 2 | EFO_1000965 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| AAAQQLQGLAFWQGV | 181 | Q9H313 | |
| IQNNLWAGNASGGSV | 221 | Q15699 | |
| TGVWQLAQAIEVVQG | 81 | Q86VI1 | |
| QGLGSEATWLDQAIQ | 616 | Q17RC7 | |
| WGFNTNQEIFQEVVG | 316 | P11597 | |
| QFAAQANAIGPWIQN | 641 | P35609 | |
| WLSVDGGNTFQLIAN | 431 | Q9H7T0 | |
| GGFLVLSNQNHQWDQ | 896 | Q9NY47 | |
| QEQNQQNGEVLGWPE | 611 | P12821 | |
| NLRAGSQEFWANGTQ | 141 | Q9UIF9 | |
| NVVENWQAGHSIFQA | 901 | Q6V0I7 | |
| LGQQAGTFNWDNLLN | 4921 | Q6V0I7 | |
| GNVTVQWVATINGQL | 2266 | Q8WXG9 | |
| QWVATINGQLATGDL | 2271 | Q8WXG9 | |
| NLAGQSLKFENGQWI | 46 | Q9Y3M2 | |
| QFIWEEAHGQQSEQG | 1886 | Q8IYW2 | |
| QGSLAVGQNWLLDEQ | 146 | Q9NR61 | |
| ITFLEGQETGIQWNN | 3726 | Q86UQ4 | |
| NGGFSQEQLNWLNEV | 211 | Q3LIE5 | |
| ITNNVIGQGLVWDFV | 866 | P15144 | |
| GEGFLSIWQVNQTAS | 2826 | Q8TDJ6 | |
| VGVIYSQNGNNPQWE | 586 | Q96K78 | |
| RQFQNGNDVNDWVGP | 361 | P19961 | |
| QLWLSDQLGQAVGQQ | 956 | O14529 | |
| FSINEQGWLQAPSQG | 181 | A6H8M9 | |
| AQWQSFQLEGGLKQF | 176 | P01023 | |
| VQEQAVWALGNIAGD | 186 | O15131 | |
| LQEWEAEQGTQASNG | 341 | Q9P2K3 | |
| QWANTGAAVFGTQSV | 2871 | P49792 | |
| GLWAVYTTNQNAGNI | 331 | O95897 | |
| TPVFDNIWNQGLVSQ | 196 | P0DJD9 | |
| RQFQNGNDVNDWVGP | 361 | P04746 | |
| QGQWGTVCDDNFAIQ | 51 | Q96JB6 | |
| VVSTGLIQNGDWTFQ | 171 | Q30154 | |
| FGNVIRWHNQETGEQ | 26 | O14920 | |
| EWQEAGVNGRYNQVL | 111 | Q86W26 | |
| QTAAVLQAWPGGTQQ | 741 | Q86Z02 | |
| NFSWQIQNEQKGITG | 516 | Q8NCI6 | |
| IGNTVNPIWQAEQFS | 256 | Q76N89 | |
| NQVAFGVQGLGWVYE | 396 | Q8N3Y1 | |
| FNQNWQDGKALGALV | 161 | O75369 | |
| QAWSQGLSGQGIVVS | 141 | Q6UW60 | |
| LSVVWNGNFVIDNPQ | 786 | Q9UIW2 | |
| NLAVDFAVVWNGNFI | 776 | O75051 | |
| FAVVWNGNFIIDNPQ | 781 | O75051 | |
| AAAFQKGLQAAVQQW | 71 | P53370 | |
| GGENIKQANWLSVSN | 61 | P17858 | |
| VGWNIQGVHTQGYNN | 131 | Q96LB8 | |
| GRAQAEQWAAEFIQQ | 236 | P50542 | |
| AFGSDGAQVQSQLLW | 301 | Q8N8M0 | |
| NGGNATLQVDNWPVN | 1186 | Q9Y4C0 | |
| VNAIEFSNNGGQWLV | 56 | Q96JK2 | |
| GSANLQTQWNIVGEF | 516 | Q2PZI1 | |
| QTQWNIVGEFSNLPQ | 521 | Q2PZI1 | |
| NSGAWQIGLANFVGI | 416 | P63132 | |
| NDTNFVLGNAQIVDW | 26 | O95259 | |
| EQQFQQKTAVWGGQE | 611 | Q6ZU52 | |
| SWVQAQGACQELGAQ | 696 | Q9UBG0 | |
| QAQSSVSLQQGWVQG | 1271 | Q9BZA7 | |
| WQQAASGVLVAVGRQ | 106 | Q8NDA8 | |
| VSIGAFGQVVQLWSQ | 636 | P17301 | |
| NSGAWQIGLANFVGI | 416 | P63135 | |
| LWAAFEEQQGNINEA | 426 | Q86UA1 | |
| TPVFDNIWNQGLVSQ | 196 | P0DJD8 | |
| EGVLLQYSNNGGIQW | 1151 | P78509 | |
| NSGAWQIGLANFVGI | 416 | Q9QC07 | |
| QNSQADNFDWVLGVG | 1531 | Q5VYJ5 | |
| TNNQADIATQGWFIG | 1206 | O94856 | |
| GITFIDDTGQQNWLQ | 101 | Q9Y2L6 | |
| VVSTGLIQNGDWTFQ | 171 | P79483 | |
| CGQGAQFLEAQIIQW | 436 | A4D1B5 | |
| GWLAAALGTNLQVQF | 241 | O00115 | |
| AIQAFGNGSDVTVWQ | 341 | P56159 | |
| FAVLQENVAWGNGRV | 1291 | Q9Y6R7 | |
| VALLQQAQGQWVQVG | 46 | Q9UBL6 | |
| SALGQAWVGFVVQAV | 301 | Q6NUI2 | |
| TGNVEGQWFLNQGTL | 301 | Q9UBX1 | |
| VVSTGLIQNGDWTFQ | 171 | P13762 | |
| QVAQTTGGLSVWQFL | 171 | Q9H4E7 | |
| VSEAWQQVQQQLDGG | 101 | Q9BUT9 | |
| LQGLATNQPFFWEAQ | 196 | Q9Y6V7 | |
| EVALNQVDVWGAQAG | 61 | Q9Y3B6 | |
| DQVLQINGENCAGWS | 156 | O00560 | |
| LWVGASVQQGVVQSL | 991 | P53992 | |
| GALWGLQAQAVQTEQ | 151 | Q6ZMJ2 | |
| AIEVQGEQQAWFGFA | 161 | Q13555 | |
| AIEVQGDQQAWFGFA | 161 | Q13557 | |
| PGQQFTWENSNLEVN | 1361 | P10586 | |
| QSSVSLQQGWVQGAN | 1266 | Q9BZA8 | |
| LQQGWVQGANGLCSV | 1271 | Q9BZA8 | |
| TPVFDNIWNQGLVSQ | 196 | P0DJD7 | |
| SIFPGDVAQQLWQGQ | 496 | P33402 | |
| DWGQQTNSFLAQAGT | 371 | O60478 | |
| NENDNQTGLWTELGN | 486 | Q92990 | |
| QTGLWTELGNIENNF | 491 | Q92990 | |
| NVANGFIALVNVIDW | 21 | P59542 | |
| AIEVQGDQQAWFGFA | 161 | Q13554 | |
| IKFLQNGSDNWNGGQ | 391 | O14607 | |
| VEQGATVNQADNEGW | 121 | Q9BZL4 | |
| GNGALTWVTLFDQNN | 16 | Q02880 | |
| IGNFDWVGNDFTQNA | 451 | Q8N7P1 | |
| FWNGVQTNPFLNGNV | 161 | Q9P0V3 | |
| DNWAFGQQTVTGQAN | 1316 | A0AVI2 | |
| AILQLGGFTVNNWTE | 131 | O60934 | |
| EDQSWGGQATNVFVN | 326 | Q9HB40 | |
| QEQAVWALGNIAGDS | 186 | P52294 | |
| NGGNATLQVDNWPVN | 181 | Q9HDB5 | |
| QEWQNSIQKNAGLAF | 1946 | Q8NFP9 | |
| AEALNVFQQAADWIG | 511 | Q9Y2G9 | |
| ANGIWQDGLSTAVQT | 61 | Q96JW4 | |
| AVWVQFNDGSQLVVQ | 906 | O00444 | |
| DAVIWGTGQLFQAQQ | 746 | Q12769 | |
| QAIREFIQGQGGWEN | 146 | Q5TBC7 | |
| GQAAWQDCQGVQGLL | 801 | Q6ZRI6 | |
| NSGAWQIGLANFVGI | 416 | P63136 | |
| GGQNAVLQVFTAASW | 111 | P57727 | |
| QDAAAVQLWVNIVNG | 501 | Q8WUH2 | |
| VLEQWQRNGFGENIS | 156 | P52742 | |
| QEQQGQLLEVGWNNT | 101 | O95857 | |
| VSGNQAGELILWQEA | 2296 | Q99973 | |
| QQNLGDIFQNQWGLS | 496 | Q7Z417 | |
| WLSLVGNNIGSVGAQ | 931 | Q9HC29 | |
| QTLVQVWVGGQLFQA | 6 | C9JR72 | |
| NSGAWQIGLANFVGL | 416 | P10266 | |
| NSGAWQIGLANFVGI | 416 | P63133 | |
| NSGAWQIGLANFVGI | 416 | Q9UQG0 | |
| GNWGNQIEFVLTSVG | 101 | P48067 | |
| EGLQNSVWQGLVFQL | 41 | Q5VVX9 | |
| LAVLFENGNIAVWQF | 276 | Q9UKN8 | |
| ENGNIAVWQFQLPFV | 281 | Q9UKN8 | |
| WQVEGDGQSFSINFN | 711 | Q6ZN44 | |
| TAAGQEQATGEWQTQ | 876 | Q9P2E3 | |
| SQLQEQGNSLGQVWA | 131 | Q9UJU3 | |
| WQGLGEVLQAQGQNE | 816 | Q9ULT0 | |
| FSWINQKVNFDNVGN | 1231 | Q9UI33 | |
| QEGNLERVNFWSAVN | 186 | Q13445 | |
| AFINSGAWQIGLANF | 416 | Q9WJR5 | |
| LQEQQALGVEAWAAG | 196 | Q6NUN9 | |
| AVDSNGNIIVADWGN | 676 | Q9C040 | |
| AKSELGAVIFWGQNQ | 126 | Q8TB96 | |
| GAVIFWGQNQTLDPN | 131 | Q8TB96 | |
| QQLVNSAGAQDRIGW | 296 | O95363 | |
| ESWNNINTNEFPNIG | 1231 | Q5T4S7 | |
| NQAAQGQWEDVVVVG | 626 | O95185 | |
| NSNNDRGVVQGQWQG | 226 | O95932 | |
| TNFQVNTNKGGGVWE | 561 | Q8NDV7 | |
| QGEETFENWLTQVNG | 56 | Q6PEW1 | |
| ENNNGLGNWRNVSGQ | 276 | Q9UPQ9 | |
| AVDSNGNIIVADWGN | 676 | O75382 | |
| GNVVEGLSAEQQEQW | 451 | Q5THJ4 | |
| QAVNSGQLQAFDWGN | 296 | Q5VXJ0 |